血栓形成中的等离子原激活剂抑制剂:结构分析和潜在的自然抑制剂
Roney V Dos Santos1,2, Manoel Victor Frutuoso Barrionuevo3, Mikael Rangel Fernandes Vieira4
1School of Pharmaceutical Sciences, UNICAMP, Campinas, SP 13083-871, Brazil.
ACS omega
|July 7, 2025
概括
血原激活剂抑制剂 (PAI) 调节血液凝块. 这项研究揭示了PAI的结构洞察力,并确定了天然化合物,如沙尔维阿诺酸B,作为对血栓形成的潜在治疗方法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 血栓形成涉及过度的血块形成,由纤维溶解系统调节.
- 血原激活剂抑制剂 (PAI),特别是PAI-1,PAI-2和PAI-3,是纤维素分解的关键调节剂.
- 了解PAI结构对于开发向抗凝固疗法至关重要.
研究的目的:
- 分析PAI-1,PAI-2和PAI-3的二级和三级结构.
- 调查它们的进化关系和保存的功能领域.
- 为了确定天然产品衍生抑制剂,用于潜在的抗凝固疗法.
主要方法:
- 对PAI-1,PAI-2和PAI-3进行了全面的结构分析.
- 比较的家族遗传学分析.
- 结构叠加和RMSD计算.
- 分子对接和分子动力学模拟.
主要成果:
- 详细分析PAI-1,PAI-2和PAI-3的二级和三级结构.
- PAI-2和PAI-3的结构相似性比PAI-1更接近.
- 萨尔维阿诺酸B和坦西二甲硫酸盐显示出高结合亲和力和稳定性作为潜在的抑制剂.
结论:
- 对PAI的结构洞察力有助于理解它们的抑制机制.
- 天然化合物,特别是盐酸B和坦西二甲硫酸盐,显示出作为新型纤维解质剂的前景.
- 这些发现支持开发用于血栓性疾病的新治疗策略.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
919
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
919
Clot Retraction and Fibrinolysis
6.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
652
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
652
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Venous Thrombosis III: Interprofessional Care
26
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
26
Formation of the Platelet Plug
7.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.1K


